Oxcarbazepine Suspension
Product Images NDC 68094-123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68094-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxcarb 01)

FDA Label Image

Figure 1 (Oxcarb 02)

Figure 1 (Oxcarb 02)
This text provides results from a Tog-rank test, specifically the p-value which is 0.0001. There is also a table showing a time trial from Day 2 with the corresponding days from Day 1, as well as an observation in the Treatment Group relating to Oxcarbazeping.*
FDA Label Image

Figure 2 (Oxcarb 03)

Figure 2 (Oxcarb 03)
The text is a statistical analysis of the seizure rate between two groups, one that received oxcarbazepine treatment and another that received placebo. The log-rank test p-value was found to be 0.046, suggesting a statistically significant difference between the groups in terms of their seizure rates. The graph shows the number of days from the first dose to the first seizure, ranging from 0 to 140 days.*
FDA Label Image

Figure 3 (Oxcarb 04)

Figure 3 (Oxcarb 04)
This is a survival analysis result where a log-rank test was performed, resulting in a very low p-value of 0.0001. The graph shows the time to exit in days and indicates the treatment group (HIGH or LOW).*
FDA Label Image

Figure 4 (Oxcarb 05)

Figure 4 (Oxcarb 05)
This is a statistical analysis output showing the log-rank test results with a p-value of 0.0001. The remaining text is not readable and appears to be a combination of characters and symbols. Therefore, no additional useful information can be extracted from the text.*
FDA Label Image

Principal Display Panel (5 mL Cup Label)

Principal Display Panel (5 mL Cup Label)
This is a description of a prescription medication called PrecisionDose™ OXcarbazepine Oral Suspension. This medication comes in a bottle that delivers 5 mL of a solution containing 300 mg of the active ingredient, oxcarbazepine, which is used to treat seizures. The NDC (National Drug Code) for this medication is 68094-123-59. The manufacturer of the medication is Precision Dose, Inc. based in South Beloit, Illinois. The medication should be shaken well before use and stored at a temperature between 20°C and 25°C (68°F and 77°F). This medication is available by prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.